Sun Pharmaceutical launches Leqselvi in US for severe alopecia areata
Leqselvi is an oral drug that selectively inhibits Janus kinases JAK1 and JAK2. It has been approved for adult patients experiencing severe forms of alopecia areata, an autoimmune